About us
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read more
- GSK Annual report 2020PDF - 36.3MB
We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Every day, we help improve the health of millions of people around the world.
Our goal is to become one of the world’s most innovative, best performing and trusted healthcare companies.
What we do
We have a significant global presence with commercial operations in more than 150 countries, a network of 89 manufacturing sites, and large R&D centres in the UK, USA, Belgium and China.
In Nigeria, our commercial office is located in Ilupeju, Lagos.
Consumer Healthcare
Our Consumer Healthcare business develops and markets products in Pain relief, Oral health, Digestive health. It has a portfolio of some of the world’s most trusted and bestselling brands which includes Sensodyne, Voltaren, Otrivin and Panadol.
We are one of the world’s leading over-the-counter (OTC) medicines company. We hold number one positions in OTC medicines across 36 markets, and are market leaders in specialist oral care.
We have a portfolio of loved and trusted brands that are underpinned by science including: Sensodyne, Andrews ,Voltaren, Panadol, Otrivin and Horlicks.
Our marketplace
Today, people are taking an increasingly active role in managing their own health. This is being fuelled by an emerging global middle class, rising healthcare costs and ageing populations. Demand for consumer healthcare products is growing, particularly in emerging markets (like Nigeria) where consumers are seeking more affordable and accessible products.
Consumer healthcare products are dependent on brand loyalty and trademark protection. Some of our heritage brands such as Macleans and Andrews continue to be popular household names today.
Our strategy
Our strategy is to combine the best of our pharmaceutical and Fast Moving Consumer Goods (FMCG) capabilities to become the first and best Fast Moving Consumer Healthcare Company driven by science and values.
To do this we are focused on building strong global brands, relentless innovation, best in class interactions with retailers, healthcare professionals and shoppers, the highest quality products at the right time and cost, and talented committed people.
Research for product innovation
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations, make them more accessible to the people who need them, and to develop benefits our consumers’ value, ultimately growing our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
You can find out more about our R&D work on Consumer Healthcare products in our Research section.
Pharmaceuticals and Vaccines
Our Pharmaceuticals business discovers, develops and makes medicines to treat a broad range of the world's most common acute and chronic diseases.
Our strategy is to bring more medicines of value to more people who need them working in partnership with governments, NGOs and academia . We will do this by building an integrated and local healthcare company with the capabilities, people and portfolio to reach more patients and consumers in the Nigeria than ever before.
In Nigeria, our business is made up of innovative and established medicines, and holds leading positions in Respiratory, Vaccines and Anti-infectives portfolios among others. Our Global Pharmaceuticals R&D organization drives the discovery and development in several core areas of research: HIV and infectious diseases, oncology, immuno-inflammation, respiratory and rare diseases.
Click to find more about our prescription medicines and vaccines in Nigeria.
How we do it
Everyone at GSK is focused on our 3 long-term priorities – Innovation, Performance, Trust, all powered by our performance-focused culture.
Innovation
Innovation is at the heart of delivering GSK’s purpose, by using our science to develop better medicines, vaccines, and consumer healthcare products. We invest in scientific and technical excellence to develop and launch a pipeline of new products that meet the needs of patients, payers and consumers.
-
£4.6bn
adjusted R&D investment in 2020
-
40
new medicines in development at FY 2020
-
17
new vaccines in development at FY 2020
Performance
We deliver growth by investing effectively in our business, developing our people and executing competitively.
-
£34bn
turnover in 2020
-
£9bn
adjusted operating profit in 2020
-
£5.4bn
free cash flow in 2020
-
£4bn
dividends paid in 2020
Trust
We are a responsible company – using our science and technology to address health needs, we are focused on making our products affordable and available and being a modern employer.
-
84%
employee engagement score on our latest employee survey
-
£250m
donated in 2020 to community health programmes
-
1st
in Access to Medicines Index since the assessment began in 2008
